Home › Funds › NOESIS CAPITAL MANGEMENT CORP › REGN
NOESIS CAPITAL MANGEMENT CORP position in REGN
REGENERON PHARMACEUTICALS · Health Care
NOESIS CAPITAL MANGEMENT CORP reported holding 33,160 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$25.1M, representing 2.98% of its reported portfolio and ranking #11 among its reported holdings. NOESIS CAPITAL MANGEMENT CORP has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NOESIS CAPITAL MANGEMENT CORP's REGN position evolved
NOESIS CAPITAL MANGEMENT CORP first disclosed a stake in REGN in Q1 2025 at 400 shares (US$254K). The position peaked in Q3 2026 at 33,160 shares, worth US$25.1M. Across 7 filings, NOESIS CAPITAL MANGEMENT CORP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 33,160 shares valued at US$25.1M. Notable position changes include a 5191% increase in Q3 2025 (shares rose 36% over the following quarter), a 55% increase in Q2 2026 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 400 | $253.69K | New |
| Q2 2025 | 400 | $210.00K | Hold |
| Q3 2025 | 21.16K | $11.90M | Add |
| Q4 2025 | 21.39K | $16.51M | Add |
| Q1 2026 | 21.38K | $16.52M | Hold |
| Q2 2026 | 33.20K | $20.70M | Add |
| Q3 2026 | 33.16K | $25.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on NOESIS CAPITAL MANGEMENT CORP
FAQ
How long has NOESIS CAPITAL MANGEMENT CORP held REGN?
NOESIS CAPITAL MANGEMENT CORP has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is NOESIS CAPITAL MANGEMENT CORP's current position in REGN?
As of Q3 2026, NOESIS CAPITAL MANGEMENT CORP holds 33.16K shares of REGN (REGENERON PHARMACEUTICALS), valued at $25.14M, representing 2.98% of its reported portfolio and ranking #11.
Has NOESIS CAPITAL MANGEMENT CORP been buying or selling REGN?
In the latest 13F filing (Q3 2026), NOESIS CAPITAL MANGEMENT CORP held unchanged its position in REGN. The position peaked in Q3 2026 at 33.16K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.